ROS‐Responsive Hydrogel Enables Drug/Ion/Gas Co‐Delivery for Improving Survival of Multi‐Territory Perforator Flap in Diabetes
Source abstract
Abstract
Abstract The multi‐territory perforator flap is a widely used microsurgical technique for repairing skin and tissue defects in diabetes. In the diabetic microenvironment, oxidative stress and inflammation from reactive oxygen species (ROS) lead to compromised blood supply to the flap, resulting in challenges for survival. The common complication of multi‐territory perforator flap is distal necrosis, which is primarily attributed to the Choke zone, the critical location characterized by delayed blood supply and inadequate neovascularization. To address this issue, a ROS‐responsive MSL@Z/G hydrogel is developed by encapsulating metformin‐Sr‐L‐Arg@ZIF‐90 (MSL@Z) nanoparticles into gelatine methacrylamide (GelMA), enabling the release of metformin, Sr ions and NO. The enhanced deformation resistance and compressive strength properties of the MSL@Z/G hydrogel make it suitable for tissue reconstruction and drug delivery. Additionally, the MSL@Z/G hydrogel exhibits antioxidant and anti‐inflammatory effects, thereby modulating the vascular microenvironment. In the dorsal multi‐territory perforated flap model of type 2 diabetic rats, the MSL@Z/G hydrogel demonstrates the ability to alleviate inflammation and promote neovascularization of the Choke zone, reducing distal necrosis, which holds great promise for improving flap survival in diabetes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Reconstructive Surgery and Microvascular Techniques · Bone fractures and treatments · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics Trauma and Microsurgery Zhongnan Hospital of Wuhan University Wuhan Hubei 430071 China
State Key Laboratory of New Textile Materials and Advanced Processing Technologies Wuhan Textile University Wuhan Hubei 430200 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Hubei Province · China Postdoctoral Science Foundation
References (60)
Show source-provided references
1. 10.1016/j.nantod.2024.10235810.1016/j.nantod.2024.102358 ↗
2. 10.1002/adfm.20221403610.1002/adfm.202214036 ↗
3. 10.1097/PRS.000000000000226310.1097/PRS.0000000000002263 ↗
4. 10.1097/PRS.000000000001123110.1097/PRS.0000000000011231 ↗
5. 10.1016/j.heliyon.2023.e1790910.1016/j.heliyon.2023.e17909 ↗
6. 10.1016/j.ijsu.2017.04.05910.1016/j.ijsu.2017.04.059 ↗
7. 10.1126/scitranslmed.aau621010.1126/scitranslmed.aau6210 ↗
8. 10.1002/micr.3064010.1002/micr.30640 ↗
9. 10.1097/01.prs.0000475776.22020.b610.1097/01.prs.0000475776.22020.b6 ↗
10. Tao X. Y. · Zhonghua Shao Shang Za Zhi Zhonghua Shaoshang Zazhi Chin. J. Burns · 2016 · 32 · 396
11. 10.1016/j.biopha.2023.11588710.1016/j.biopha.2023.115887 ↗
12. 10.1016/j.bjps.2022.02.05610.1016/j.bjps.2022.02.056 ↗
13. 10.1016/j.intimp.2020.10719210.1016/j.intimp.2020.107192 ↗
14. 10.1038/s41467-023-37959-y10.1038/s41467-023-37959-y ↗
15. 10.1016/j.bcp.2022.11512210.1016/j.bcp.2022.115122 ↗
16. 10.1016/j.jconrel.2022.09.02610.1016/j.jconrel.2022.09.026 ↗
17. 10.1002/adfm.20220285710.1002/adfm.202202857 ↗
18. 10.1016/j.biomaterials.2022.12157710.1016/j.biomaterials.2022.121577 ↗
19. 10.1007/s40820-020-00542-x10.1007/s40820-020-00542-x ↗
20. 10.1016/j.cej.2023.14808810.1016/j.cej.2023.148088 ↗
21. 10.1001/jama.2019.380510.1001/jama.2019.3805 ↗
22. 10.1038/s41574-019-0242-210.1038/s41574-019-0242-2 ↗
23. 10.1002/smll.20240780210.1002/smll.202407802 ↗
24. 10.1016/j.cej.2021.13106410.1016/j.cej.2021.131064 ↗
25. 10.1016/j.jconrel.2024.08.01110.1016/j.jconrel.2024.08.011 ↗
26. 10.1016/j.cej.2023.14406710.1016/j.cej.2023.144067 ↗
27. 10.1016/j.jconrel.2024.01.01410.1016/j.jconrel.2024.01.014 ↗
28. 10.1097/PRS.000000000001084310.1097/PRS.0000000000010843 ↗
29. 10.1097/00000637-200108000-0000710.1097/00000637-200108000-00007 ↗
30. 10.1016/j.biomaterials.2018.06.00410.1016/j.biomaterials.2018.06.004 ↗
31. 10.1016/j.nantod.2023.10186110.1016/j.nantod.2023.101861 ↗
32. 10.1007/s12011-022-03504-z10.1007/s12011-022-03504-z ↗
33. 10.1002/chem.20150500510.1002/chem.201505005 ↗
34. 10.1186/s40824-023-00361-210.1186/s40824-023-00361-2 ↗
35. 10.1016/j.biomaterials.2020.12028610.1016/j.biomaterials.2020.120286 ↗
36. 10.1002/advs.20220254210.1002/advs.202202542 ↗
37. 10.7150/thno.3736210.7150/thno.37362 ↗
38. 10.1002/adma.20241337110.1002/adma.202413371 ↗
39. 10.1002/sstr.20240001410.1002/sstr.202400014 ↗
40. 10.1002/adma.20231367210.1002/adma.202313672 ↗
41. 10.1016/j.jhazmat.2021.12670410.1016/j.jhazmat.2021.126704 ↗
42. 10.1038/s41392-023-01499-010.1038/s41392-023-01499-0 ↗
43. 10.1002/advs.20231028510.1002/advs.202310285 ↗
44. 10.1038/s41392-023-01668-110.1038/s41392-023-01668-1 ↗
45. 10.1021/acsnano.4c0633210.1021/acsnano.4c06332 ↗
46. 10.1126/sciadv.adi107810.1126/sciadv.adi1078 ↗
47. 10.1016/j.cell.2015.12.05710.1016/j.cell.2015.12.057 ↗
48. 10.1007/s11434-015-0773-410.1007/s11434-015-0773-4 ↗
49. 10.1126/sciadv.adj319410.1126/sciadv.adj3194 ↗
50. 10.1186/s12951-022-01328-610.1186/s12951-022-01328-6 ↗
51. 10.1038/s41413-023-00279-410.1038/s41413-023-00279-4 ↗
52. 10.1093/cvr/cvae20510.1093/cvr/cvae205 ↗
53. 10.7150/thno.2189510.7150/thno.21895 ↗
54. 10.1016/j.bioactmat.2024.03.03710.1016/j.bioactmat.2024.03.037 ↗
55. 10.1016/j.canlet.2012.08.01810.1016/j.canlet.2012.08.018 ↗
56. 10.1021/acsami.8b0386810.1021/acsami.8b03868 ↗
57. Kowluru R. A. · Biol. Med. · 2009 · 46 · 1677
58. 10.1016/j.bioactmat.2022.01.00410.1016/j.bioactmat.2022.01.004 ↗
59. 10.1021/acsnano.1c0942710.1021/acsnano.1c09427 ↗
60. 10.1002/adfm.20240609810.1002/adfm.202406098 ↗